Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05898711 · ClinicalTrials.gov registry record

Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement

A clinical trial of Surgery--Complications, sponsored by Kerecis.

Active
Registry status
200
Enrollment target
1
Study location

NCT05898711: Active study of Surgery--Complications, sponsored by Kerecis.

NCT05898711 is a study of Surgery--Complications that is active but no longer recruiting, run by Kerecis. The registered enrollment target is 200 participants, below the 2,724-participant average among 11 other Surgery--Complications trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05898711, a study of Surgery--Complications, is active but no longer recruiting, sponsored by Kerecis.

ACTIVE NOT RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Registry Objectives The overall objective of the registry is to collect quality and safety data to assess the long-term outcomes of Kerecis Omega3 SurgiBind in surgical procedures to reinforce soft tissue and prevent surgical complications. The ultimate goal of the registry is to enhance the quality of care, patient outcomes and establish a resource to facilitate the use of fish skin in preventing surgical wound dehiscence and surgical site infection.

Primary Outcome

quantify the number of patients who experience postoperative wound complications including dehiscence and infection. Patients undergoing surgical procedures and experience wound complications are captured. Wound dehiscence will be categorized as superficial or deep. Infection (if appears) will be identified and recorded. Wounds are considered infected if the wound margins are erythematous and have one or combined of the following: active purulence or necrosis of underlying soft tissues.

Conditions Studied

Interventions

  • DEVICE Fish skin graft

Study Locations (1)

Virginia

  • Kerecis - Arlington

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-01-27
Est. Completion 2026-01-27
Kerecis

7 total trials

What the registry record for NCT05898711 still lists

NCT05898711 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,724-participant average among 11 other Surgery--Complications trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Surgery--Complications appearing as the primary indexed condition, and to 1 intervention - of which Fish skin graft is the first listed.

NCT05898711 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT05898711 about?

NCT05898711 is a clinical study titled "Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement". Registry Objectives The overall objective of the registry is to collect quality and safety data to assess the long-term outcomes of Kerecis Omega3 SurgiBind in surgical procedures to reinforce soft tissue and prevent surgical complications. The ultimate goal of the registry is to enhance the quality...

What is the current status of trial NCT05898711?

This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2022-01-27. Estimated completion is 2026-01-27.

What conditions does trial NCT05898711 study?

This clinical trial studies the following conditions: Surgery--Complications.

What interventions are being tested in trial NCT05898711?

The interventions under investigation include: Fish skin graft (DEVICE).

Who is sponsoring clinical trial NCT05898711?

This trial is sponsored by Kerecis, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05898711 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery--Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05898711's enrollment target sits among peer trials

200 5th of 11 higher than 7 of 11 other Surgery--Complications trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery--Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05898711, the US trial registry maintained by the National Library of Medicine. NCT05898711 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.